FDA Inspection 1234762 — EUGIA Pharma Specialities Limited
The FDA completed an inspection of EUGIA Pharma Specialities Limited on November 25, 2022 in Medchal-Malkajgiri District. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 25, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Medchal-Malkajgiri District (India)
Additional Details
Mutual Recognition Agreement (MRA)